Product image of Lacosamida (Lacosamide) supplied by GNH India

Lacosamida

Active Ingredient:
Lacosamide
Origin:
EU

Lacosamida (Lacosamide)

Lacosamide, the active ingredient in Lacosamida, is an Anticonvulsant presented as an oral dosage form for oral use. It is employed to treat partial‑onset seizures in patients diagnosed with epilepsy, helping to reduce seizure frequency and improve neurological stability.

GNH India supplies Lacosamida as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Manufacturer / TM Owner

Jubilant Pharmaceuticals Nv

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Lacosamide is an anticonvulsant that targets neuronal hyperexcitability in epilepsy and related seizure disorders.

  • Partial‑onset seizures: reduces seizure frequency in patients with focal epilepsy.
  • Epilepsy (adjunct therapy): provides additional seizure control when other agents are insufficient.
  • Refractory focal epilepsy: offers an alternative mechanism for patients not responding to standard treatments.

How It Works

  • Lacosamide enhances the slow inactivation of voltage‑gated sodium channels, stabilizing hyperexcitable neuronal membranes and limiting repetitive firing. By selectively targeting the slow inactivation phase, it reduces the likelihood of abnormal depolarization without markedly affecting normal neuronal activity, thereby contributing to seizure control in epilepsy.

Side Effects

Lacosamide may cause a range of adverse reactions, from mild to serious. Patients should be aware of both common and rare events.

Common Side Effects

  • Dizziness: feeling light‑headed or unsteady.
  • Nausea: upset stomach or urge to vomit.
  • Headache: mild to moderate pain in the head.
  • Fatigue: unusual tiredness or lack of energy.
  • Blurred vision: temporary visual disturbances.
  • Diplopia: double vision.

Serious or Rare Side Effects

  • Suicidal thoughts: emergence of depressive or suicidal ideation.
  • Severe rash: including Stevens‑Johnson syndrome.
  • Cardiac arrhythmia: prolongation of PR interval on ECG.
  • Hypersensitivity: anaphylactic reactions or angioedema.
  • Liver enzyme elevation: significant increase in hepatic transaminases.

Precautions & Warnings

Before initiating therapy, clinicians should evaluate patient‑specific risk factors and monitor for potential complications.

  • Cardiac monitoring: assess PR interval and conduction abnormalities.
  • Renal function: adjust dosing in severe renal impairment.
  • Hepatic function: monitor liver enzymes periodically.
  • Pregnancy counseling: discuss limited data and potential risks.
  • Concomitant CNS depressants: use with caution due to additive sedation.
  • Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Avoid Interactions

Lacosamide can interact with several drug classes, requiring careful management.

Major Interactions (Avoid)

  • Carbamazepine: may reduce lacosamide plasma levels.
  • Phenytoin: can increase risk of cardiac conduction effects.
  • Strong CYP3A4 inhibitors: may elevate lacosamide concentrations.

Moderate Interactions (Monitor Closely)

  • Other antiepileptics (e.g., valproate): monitor for additive CNS depression.
  • Anticoagulants: watch for altered bleeding risk.
  • Alcohol: increased sedation and dizziness.

Frequently Asked Questions

Lacosamida contains the active ingredient lacosamide, an anticonvulsant prescribed to control partial‑onset seizures in patients with epilepsy. It is used as an adjunct or monotherapy to reduce seizure frequency and improve overall neurological stability.

Lacosamide enhances the slow inactivation of voltage‑gated sodium channels in neuronal membranes. This stabilizes hyperexcitable neurons, limiting repetitive firing that leads to seizures, while preserving normal neuronal activity.

The dosage of Lacosamida is individualized by a qualified prescriber based on the patient’s clinical condition, age, renal function, and response to therapy. Only a healthcare professional can determine the appropriate regimen.

Safety data for lacosamide in pregnancy and lactation are limited. Clinicians should weigh potential benefits against unknown risks and discuss options with the patient. Breastfeeding decisions should be made in consultation with a healthcare provider.

To request Lacosamida, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, confirming trade or institutional credentials before providing pricing, availability, shipping details and import documentation.

Lacosamide offers a distinct mechanism by enhancing slow sodium channel inactivation, which can be advantageous for patients who have not responded to drugs that target fast inactivation. It is generally well‑tolerated and may be combined with other antiepileptics, though drug‑specific efficacy and safety profiles vary.

Lacosamida should be stored at ambient temperature, below 25 °C, in its original container to protect from moisture and light. Keep the product out of reach of children and avoid exposure to extreme temperatures.

Lacosamida is taken orally, usually as a tablet or oral solution, with or without food as directed by the prescriber. The exact administration schedule is determined by the treating physician based on individual therapeutic needs.

Serious risks include cardiac conduction abnormalities such as PR‑interval prolongation, severe skin reactions like Stevens‑Johnson syndrome, and emergence of suicidal thoughts or behaviors. Patients should be monitored regularly for these events, especially during treatment initiation.

Lacosamida is contraindicated in patients with known hypersensitivity to lacosamide or any of its excipients. Caution is advised for individuals with pre‑existing cardiac conduction disorders, severe renal impairment, or those taking interacting medications that could increase toxicity.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Lacosamide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT